Please Enable JavaScript

www.cablinginstall.comis using a security service for protection against online attacks.
The service requires full JavaScript support in order to view this website.

Please enable JavaScript on your browser and try again.

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Biotech ETFs Could Be in for More Pain Ahead

By: ETF Trends

May 02, 2022 at 12:01 PM EDT

After suffering one of their worst Aprils in years, biotech sector-related exchange traded funds could be in for even more pain ahead. Year-to-date, the SPDR S&P Biotech ETF (NYSEArca: XBI) has declined 32.2% and the iShares Nasdaq Biotechnology ETF (IBB), the largest biotech-related ETF by...

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Please Enable Cookies

Biotech ETFs Could Be in for More Pain Ahead